Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Naunyn Schmiedebergs Arch Pharmacol ; 331(1): 20-2, 1985 Oct.
Article in English | MEDLINE | ID: mdl-2933591

ABSTRACT

The decrease in the Bmax value of 3H-dihydroalprenolol (3H-DHA) binding to cortical membranes of rat brain induced by long-term administration of desipramine (DMI) was prevented by concomitant treatment with parachlorophenylalanine (pCPA). Acute administration of DMI significantly decreased locomotor activity in saline- and (pCPA)-pretreated rats. DMI-induced inhibition of locomotor activity was abolished in (pCPA)-pretreated rats chronically treated with DMI. Conversely, in pCPA-pretreated animals, acute DMI could still significantly decrease the locomotion of chronically DMI-treated rats. The data presented indicate that an intact serotoninergic system is required to enable antidepressant drugs to induce biochemical and behavioral changes following their chronic administration.


Subject(s)
Brain Chemistry/drug effects , Desipramine/pharmacology , Fenclonine/pharmacology , Motor Activity/drug effects , Animals , Drug Interactions , Kinetics , Male , Rats , Rats, Inbred Strains , Serotonin/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...